Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic Malignant Melanoma Treated With Targeted Therapies or Immunotherapy ( MALT )
Clinical trial NCT03493230 · COMPLETED
Trial details
- NCT number
- NCT03493230
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-24
- Primary completion
- 2022-11-08
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.